Moderna Says Developing Single-dose Combination Vaccine For Flu And COVID-19

Moderna Inc. (MRNA) said Thursday that it is developing a single dose vaccine that combines a booster against COVID-19 and a booster against flu.

The company announced significant advances across its portfolio of mRNA pipeline programs being presented at the Company's fifth annual R&D Day Thursday.

The company said it is making progress on enrolling patients in its rare disease programs, and it is fully enrolled in its personalized cancer vaccine trial.

Moderna continues to scale, now with 37 programs in development across 34 development candidates1, including 22 in ongoing clinical studies.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Sandoz, Inc., an unit of Novartis AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high temperatures that may have impacted product effectiveness, the U.S. Food and Drug Administration or FDA said in a statement. Livia Global, Inc., a health and wellness company, is recalling two lots of its Liviaone liquid probiotics citing the possibility of contamination by Pseudomonas aeruginosa, the U.S. Food and Drug Administration said. Pseudomonas aeruginosa is a microorganism found in the environment that, if ingested, can cause life-threatening infection in immunocompromised individuals. United Airlines operated Thursday the first ever passenger flight using 100% Sustainable Aviation Fuel or SAF as part of its efforts to combat climate change. The airline flew the green flight from Chicago's O'Hare International Airport or ORD to Washington, D.C.'s Reagan National Airport or DCA with more than 100 passengers.
Follow RTT